跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,479 条关于
“ELI-002 Amph-Peptides 7P”
全部
14,479
临床试验
5,714
药物
6,094
机构
70
资讯
2,601
去年
IDMC Recommends Continuation of ELI-002 7P Phase 2 Trial in Pancreatic Cancer Following Positive Interim Analysis
9个月前
Elicio Therapeutics' ELI-002 7P Demonstrates Antigen Spreading in 87% of Phase 2 Patients
去年
Elicio Therapeutics Completes Enrollment in Phase 2 Trial of ELI-002 for mKRAS-Driven Pancreatic Cancer
去年
Elicio Therapeutics' ELI-002 Shows Promise in KRAS-Mutated Solid Tumors
去年
Elicio Therapeutics Gains FDA Support for ELI-002 Registrational Strategy in KRAS-Mutated Cancers
6个月前
Elicio Therapeutics Reports Encouraging Phase 2 AMPLIFY-7P Trial Progress with Fewer Disease Events Than Projected
去年
Elicio Therapeutics Advances mKRAS-Targeting Cancer Vaccine, Anticipates Phase 2 Results in H1 2025
2年前
Elicio Therapeutics to Present mKRAS Vaccine Data at Multiple Conferences
10个月前
Elicio Therapeutics Appoints Marc Wolfgang as CTO to Strengthen Commercial Readiness for KRAS-Targeted Cancer Immunotherapy
2年前
Elicio's ELI-002 Cancer Vaccine Shows Promising Results in Phase 1 Trial for Pancreatic and Colorectal Cancer
第 1 页,共 261 页
上一页
下一页